Core Laboratories (CLB) Reports In-Line Q1 EPS, Offers FY and Q2 Guidance

Go back to Core Laboratories (CLB) Reports In-Line Q1 EPS, Offers FY and Q2 Guidance

Morgan Stanley Downgrades Core Laboratories (CLB) to Underweight

April 24, 2014 6:59 AM EDT

Morgan Stanley downgraded Core Laboratories (NYSE: CLB) from Overweight to Underweight.

For an analyst ratings summary and ratings history on Core Laboratories click here. For more ratings news on Core Laboratories click here.

Shares of Core Laboratories closed at $213.69 yesterday.

... More